Related Experiment Video
Updated: Apr 1, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Prediabetes in children and adolescents in Israel: a large-scale retrospective cohort study
Maya Gerstein1,2,3, Yael Reichenberg3, Herman Avner Cohen1,4
1Pediatric Ambulatory Community Clinic, Petach Tikva, Israel.
Insights
Prediabetes is rising in Israeli youth, with higher risks found in obese children, those from the Arab sector, and lower socioeconomic backgrounds. Targeted prevention strategies are crucial for early identification and reducing future type 2 diabetes risk.
Area of Science:
- Pediatric Endocrinology
- Public Health
- Metabolic Disorders
Background:
- Prediabetes prevalence is increasing globally in pediatric populations.
- Limited population-based data exist for diverse youth demographics.
- This study addresses the gap by examining prediabetes risk factors in Israeli children and adolescents.
Purpose of the Study:
- To determine the prevalence of impaired fasting glucose (IFG) and elevated glycated hemoglobin A1c (HbA1c) in non-diabetic Israeli youth.
- To identify demographic and clinical factors associated with prediabetes.
- To inform targeted prevention and screening strategies.
Main Methods:
- Retrospective cohort study of 19,654 children aged 5-18 years (2010-2020).
- Data included age, sex, sector, socioeconomic status (SES), BMI, fasting plasma glucose, and HbA1c.
- IFG defined as 100-125 mg/dL; elevated HbA1c as 5.7-6.4%.
Main Results:
- Obesity rates were higher in the 10-14 age group (44.1%).
- IFG and/or elevated HbA1c prevalence was highest in morbidly obese individuals.
- Low SES was linked to increased IFG odds (5-9 years) and prediabetes (10-18 years).
- Children from the Arab sector showed higher adjusted odds of prediabetes.
Conclusions:
- Significant disparities in prediabetes risk exist among Israeli youth.
- Risk is influenced by sex, age, obesity, sector, and SES.
- Supports targeted, age- and sector-specific screening and prevention strategies, addressing social determinants of health.
Abstract:
To determine the prevalence of impaired fasting glucose (IFG) and increased glycated hemoglobin A1c (HbA1c) among Israeli children and adolescents without diabetes. A retrospective cohort study of children aged 5-18 years from three central Israeli districts from 2010 to 2020 was conducted. Data retrieved from the electronic patient medical files included age, sex, sector, socioeconomic status (SES), body mass index (BMI), fasting plasma glucose, and HbA1c levels. IFG was defined as fasting glucose 100-125 mg/dL; increased HbA1c as 5.7-6.4%. Of the 19,654 participants (54% male), rates of obesity were higher in the 10-14-year-old group (44.1%). Prevalence of IFG and/or elevated HbA1c was highest among morbidly obese individuals across all ages. Notably, low SES was associated with increased odds for IFG in children aged 5-9 years, and increased odds for prediabetic parameters among adolescents (10-18y). Children from the Arab sector had consistently higher adjusted odds of prediabetes compared to other groups.
Conclusions:
Significant disparities exist in prediabetes risk among Israeli youth, influenced by sex, age, obesity, sector, and SES. Findings support the use of targeted, age- and sector-specific strategies for early identification and prevention, including glucose screening and efforts to address social determinants of health in pediatric care.
What Is Known:
• Prediabetes among children and adolescents has become increasingly common, yet population-based data from diverse settings are limited.
What Is New:
• This study demonstrated higher prediabetes risk among children from the Arab sector and from low socioeconomic status. • These findings support early, equitable screening and culturally tailored prevention strategies to reduce future type 2 diabetes risk.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

